The intramuscular (IM) injection of a modi ed brin meshwork plus deferoxamine was tested in a rabbit model of acute hind-limb ischemia. After excision of the left external iliac and femoral arteries, 12 rabbits at the Milwaukee Heart Institute were divided into two groups: control and brin meshwork plus deferoxamine (FDEF) IM. The rabbits underwent angiography before surgery, immediately after, and 1 month postoperatively. These data were compiled through counting by means of a grid overlay. Another 12 rabbits at the Vakhidov Center of Surgery, which did not undergo angiography, underwent lower limb-calf blood pressure (L-CBP) measurements made immediately after surgery and at postoperative days 10, 20 and 30. Biopsies from thigh skeletal muscles of rabbits that had L-CBP measurements underwent alkaline phosphatase staining on day 30 to determine the percentage of biopsied area that was occupied by capillaries. The number of arteries and arterioles crossing 71 grid intersections immediately post-surgery decreased from 30.2 6 2.3 to 18.0 6 2.0 (p , 0.05). One month postsurgery this number increased to 29.2 6 2.4 in controls (p , 0.05 vs immediately post-surgery) and to 59.6 6 3.2 in the FDEF group (p , 0.001 vs immediately post-surgery). By day 30 the L-CBP ratio improved in the FDEF group (0.8 6 0.02) vs controls (0.3 6 0.04). By day 30 the capillary density increased from that of normal muscle tissue (198.6 6 12.9/mm 2 ) to 292 6 12.4/mm 2 in the FDEF group (p , 0.05), but decreased in the control group to 98.7 6 7.7/mm 2 . IM injection of FDEF considerably accelerated angiogenesis in severely ischemic hind-limb tissue in this model, making it a viable treatment method for clinical use in patients who have critical limb ischemia.
Introduction
Approximately 500-1000 people per million worldwide have critical limb-threatening ischemia. 1 In many cases, because the extent and distribution of advanced limb ischemia precludes any percutaneous or operative revascularization, amputation is often recommended. 2 When surgical management is impossible, the attempt to avoid amputation is directed toward improving 'therapeutic angiogenesis'. 3 To accelerate these processes several angiogenic factors have been investigated. Two of these factors, broblast growth factor and vascular endothelial growth factor, seem to effectively treat hind-limb ischemia. 4 -6 Moreover, vascular endothelial growth factor (VEGF) has been used clinically to treat patients who have critical limb ischemia. 7 However, after the initial years of enthusiasm, questions have arisen about the real effect of growth factors and their clinical usefulness. 8 Efforts have turned to nding a clinically safe method to accelerate angiogenesis in severely ischemic tissue. Over the past 8 years our group has devised several approaches to accelerate neovascularization and to enhance angiogenesis in ischemic muscle tissue used for cardiobioassist. Our investigations with electrical stimulation 9 and pharmaceutical agents 1 0 showed that, even after acute severe ischemia, these strategies accelerate neovascularization. Studies from several laboratories, 1 1 ,1 2 including ours, 1 3 have shown that brin enhances angiogenesis and serves as a vehicle for delivering angiogenic growth factors. A brin meshwork is biodegradable through routine tissue brinolysis. In addition, during ischemia, iron is released from erythrocytes. This increased iron level is cytotoxic to the vascular endothelium 1 4 and acts as a catalyst for reactive oxygen metabolism. 1 5 Deferoxamine, an iron chelator, may attenuate the deleterious effects of iron on muscle tissue 1 6 and has protected human endothelial cells in vitro from reoxygenation injury. 1 4 Deferoxamine has recently been shown to activate the angiogenesis response. 1 7 Our own investigations also showed that deferoxamine is effective in treating acute ischemic syndromes. 1 8 Previously 1 9 we showed that brin injection (especially brin containing 5.0 mg brinogen) signi cantly promoted new collateral growth in hind-limb ischemia: the number of vessels crossing a speci c line was 8.5 6 0.9, and lower limb-calf blood pressure (L-CBP) ratio was 0.7 6 0.05 (1 month after artery excision).
In the present study, we used the same established rabbit model of hind-limb ischemia 4 to investigate the ef cacy of an intramuscular (IM)-injected brin meshwork plus defer-oxamine (FDEF) for enhancing angiogenesis and establishing its feasibility for clinical use.
Materials and methods
Studies with adult New Zealand white rabbits (male, mean weight 3.3 kg) complied with the National Society of Medical Research's mandates in Principles of laboratory animal care and with the National Institute of Health's Guide for the care and use of laboratory animals.
After excision of the left external iliac and femoral arteries, 12 rabbits in the Milwaukee Heart Institute were divided into two groups of six animals each: series A, control and series B, FDEF IM. When deferoxamine is administered alone, it is rapidly absorbed into the body; therefore, we used it in combination with a brin meshwork. For all 12 Milwaukee Heart Institute rabbits, angiography was performed before artery incision, as well as immediately after surgery, and 30 days after surgery.
The same surgery was performed on 12 rabbits at the Vakhidov Center of Surgery and the animals were divided into the same groups: series C, control and series D, FDEF IM. Lower limb-calf blood pressure ratio (on days 20 and 30 after surgery) and capillary density (before and at 30 days after surgery) were performed.
Rabbit hind-limb ischemia model
The rabbits were anesthetized by IM injection of ketamine (25 mg/kg), acepromazine (1 mg/kg) and glycopyrrolate (0.02 mg/kg). A longitudinal incision was made from the left inguinal ligament to a point just proximal to the patella. The left distal external iliac artery and femoral artery with its branches were dissected free, then all major branches of the femoral artery (inferior, deep femoral, lateral circumex, super cial and epigastric) were ligated, as was the distal external iliac artery. The femoral artery was excised from the point of the external artery to the bifurcation into the saphenous and popliteal arteries, leaving the internal iliac artery as the sole source of blood ow to the hind limb. The incision was closed in three layers using 3.0 silk. Chloramphenicol (30 mg/kg IM bid) was given for 10 days postoperatively to control infection and Buprenorphine (0.15 mg/kg IM bid) was given to control pain.
Fibrin sealant preparation
The brin sealant was created from two separate solutions: brinogen solution and thrombin solution. Ten days before surgery, one of the authors (VN) prepared the brinogen solution from fresh sterile rabbit plasma by a process of ammonium sulfate precipitation and glycine buffer purication. Concentration of the nal solution was made at 5.0 mg/ml. The thrombin solution was prepared by mixing thrombin dried powder and calcium chloride solution. Thrombin powder is a sterile, non-pyrogenic, freeze-dried, vapor-heated preparation made from pooled plasma. The calcium chloride solution was formulated as a sterile, nonpyrogenic solution containing 40 mmol/ml. After the lyophilized thrombin in calcium chloride solution was reconstituted, the stock thrombin solution contained 50 IU/ml of thrombin and 40 mmol/ml of calcium chloride. 100 mg of deferoxamine was added to the brinogen solution (in series B and D).
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Administration of the brin sealant Immediately after surgery, the brin sealant was administered to three sites above the excised femoral artery: (1) medial thigh; (2) lateral thigh; and (3) distal thigh near the knee. By means of an FDA-approved two-barreled syringe (one barrel containing 1.0 ml brinogen solution, the other 1.0 ml thrombin solution), simultaneous injections from both syringes were delivered to each site. When the two solutions combined, the brin sealant was formed. The sealant was applied between the femoral vein and the muscle at the site where the femoral artery was excised (in series B and D).
Lower limb-calf blood pressure ratio
Immediately after surgery and on postoperative days 10, 20 and 30, a 1050 Doppler ow meter (Parks Medical Electronics, Aloha, OR, USA) was used to measure blood pressure and to locate the pulse in the posterior tibial artery. A 2.5 cm wide blood pressure cuff was applied over the calf and in ated to 100 mmHg, then de ated for 30 s, after which systolic pressure was recorded on reappearance of the Doppler ow signal. Next, blood pressure in the calf of both the ischemic and non-ischemic limbs was measured and the systolic pressure in the ischemic limb was divided by the systolic pressure in the non-ischemic limb (L-CBP ratio). To monitor uctuations in blood pressure related to anesthesia, blood pressure was measured on the contralateral, non-ischemic limb. A single observer who was not informed of the purpose of the study performed all measurements and calculations (in series C and D).
Angiography
To perform angiography (before, immediately after and 1 month after surgery) a 22 guage infusion catheter was introduced into the right femoral artery and advanced to the lower abdominal aorta under uoroscopic guidance. After intra-arterial injection of nitroglycerin (0.25 mg), 5 ml of contrast media (Optiray 350, Mallinckrodt Inc., St Louis, MO, USA) was injected at a rate of 1 ml/s, then serial images of ischemic hind limbs were recorded for 10 s at one image per second. Collateral development was analyzed according to Tufts University Medical School guidelines 6 as follows. A 30-grid template (each square 1 cm 2 ) (71 grid intersections) was placed over the area of interest on the angiogram at the 4-s point after injection of contrast media. Three separate independent observers counted the number of contrast-opaci ed arteries (COAs) and arterioles crossing a speci ed line of the grid, the total number of grid intersections crossed by COAs and the total number of grids with COAs ( Figure 1) (in series A and B) .
Histological analysis/studies
Before the animals were sacri ced, biopsy specimens were taken from the adductor and the semi-membranous muscles for light microscopy and immunohistochemistry studies of the ischemic limb. Samples (3 3 4 mm) were placed in 10% formalin and taken to the hospital's pathology department for embedding and sectioning.
Histological determination of capillary density
Immediately after an animal was sacri ced, biopsy specimens were taken from the adductor and semi-membranous muscles for histological determination of capillary density. The samples were frozen for 30 s in a bath of liquid nitrogen. Multiple frozen sections were cut (10 mm thickness) on a cryostat and placed on glass slides. Next, the sample was stained for alkaline phosphatase using the indoxylterazolin method. A pathologist who was blinded to the series of experiments counted the number of capillaries under 20 3 objective in a chosen eld (a total of 10 elds from two different sections of the muscle tissue per sample). Capillary density was calculated as the number of capillaries/mm 2 of muscle (in series C and D).
Statistical analysis
All data are presented as mean 6 standard deviation. Comparisons within the same animal were performed by a paired Student's t-test. For comparison between groups, a one-way ANOVA was used followed by Tukey's test for multiple comparisons. A two-tailed p-value of ,0.05 was considered statistically signi cant.
Results
All rabbits tolerated limb ischemia well. No animal lost weight nor did we nd signs of muscle atrophy or necrosis in the nails or the muscle, perhaps because the external iliac artery was not excised. In two related investigations (not discussed here) we compared two variants of the surgical procedure, one in which this artery was excised above the peritoneum, after which almost all rabbits suffered severe necrosis of the skeletal muscle; all were euthanized to end their severe pain. ant the number of COAs increased to 9.8 6 0.6 (p , 0.001 vs post-surgery, p , 0.05 vs control).
Angiographic assessment (
The same change was seen in the grid intersections crossed by COAs: a signi cant decrease in the control group from 30. In normal non-ischemic muscle, the number of grids containing COAs was 19. After excision of the femoral artery, ow was seen to the distal femoral artery on angiography. One month after surgery, angiography in all series (including control) revealed progressive linear extension of collateral arteries from the origin of the stem artery to the distal point of the reconstituted parent vessels. However, in series B many vessels were seen emerging from the pelvis and running through the thigh (Figure 2) . One or two of these anastamoses connected to the distal part of the excised femoral artery to supply the hind limb with blood.
Lower limb-calf blood pressure ratio
In all rabbits no Doppler ow signal could be detected immediately after surgery or on day 10, but was detected on day 20. However, the L-CBP ratio in the control series was only 0.2 6 0.04, and in the FDEF IM group increased to 0.6 6 0.02 (p , 0.001 vs control). At day 30, this ratio further improved in both series, but was signi cant in only the FDEF IM series (0.3 6 0.04 in the control series; 0.8 6 0.02 in the deferoxamine series) (p , 0.001 vs control) (Figure 3 ).
Capillary density
On day 30, as described above, the thigh muscles were studied histologically for capillary density to evaluate the effect of deferoxamine on revascularization. Before femoral artery incision, capillary density was 198.6 6 12.9/mm 2 , 
Discussion
Several studies have established the effectiveness of angiogenic growth factors in experimental models of hind-limb ischemia. 4 -6 Moreover, VEGF has been used clinically to treat critical limb ischemia. 7 We have found that deferoxamine (delivered in a brin matrix) has similar angiogenic properties.
One possible explanation of the mechanism of deferoxamine-induced angiogenesis may be in the change in iron ion concentration. It is now known that redox-active iron can initiate lipid peroxidation, an important early event in the ischemia and vessel endothelium dysfunction.
2 0 ,2 1 It was also shown that the progression of endothelial dysfunction and lipoprotein oxidation is closely related to vascular iron deposition. 2 2 Any method that decreases the availability of iron for the production of reactive oxygen species 2 3 may be useful to restore endothelial function, including angiogenesis. 2 4 Halliwell 2 3 showed that in higher concentrations of deferoxamine, an iron chelator might scavenge reactive oxygen species.
Recently, Ryter et al 2 5 showed that regulation of endothelial heme oxygenase activity during hypoxia is dependent on chelatable iron. Colet et al 2 6 showed that reperfusion of an ischemic organ can lead to microcirculatory impairment caused, in part, by the generation of reactivefree radicals. The iron-catalyzed formation of these deleterious substances can be counteracted by strong metal chelatives like deferoxamine.
As shown in our study, local administration of a brin sealant is suf cient to revascularize an ischemic lower limb without damaging ischemic tissue. Moreover, it is suf cient to apply only brin sealant, subcutaneously and intramuscularly, to stimulate angiogenesis. In previous investigations, 1 9 ,2 7 we showed that brin sealant can activate migration of endothelial cells, macrophages and myo broblasts toward treated ischemic tissue, serving as a temporary matrix for the gradual development of granulation tissue that is characterized by a high degree of vascularity, resulting in new vessel formation within a loose collagenous interstitium.
It is known that thrombin cleaves brinogen into brin, creating a matrix that is slowly degraded by brinolysis, possibly releasing the components that were mixed with brinogen. Studies 2 8 -3 0 have shown that adding VEGF and broblast growth factor to the brin network increases angiogenesis in ischemic tissue. However, when they studied the ef cacy of brin glue implants in non-ischemic tissue, Fasol et al 3 1 found that the implants alone, without growth factors, failed to induce neovascularization in vivo.
Chalupowicz et al 3 2 showed that cells rapidly differentiate into capillary tubes when an endothelial cell monolayer is sandwiched between two layers of brin gel. When there were no added angiogenesis stimulators, Nehls and Dronckhahn 3 3 found that endothelial cells tend to migrate into a matrix that consists of a brinogen solution, which then can be induced to polymerize by adding thrombin.
In our previous investigations, 3 4 even without any intervention, we found growth of numerous collateral vessels 1 month after magistral vessels were closed and severe ischemia had been induced by means of femoral artery excision. Although all angiographic parameters signicantly decreased immediately after surgery in our current study, 1 month later all parameters were slightly (but not signi cantly) improved compared with baseline.
We also found in this study that, whether or not brin sealant was applied, both angiogenesis and arteriogenesis were affected. Initial evidence based on arteriography and histologic (immunostaining) studies indicated that angiogenesis improved to compensate for diminished blood ow in the ischemic limb and capillary density increased as did arteriogenesis. Ito et al 3 5 have suggested that angiogenesis may relieve ischemia but that only real collateral arteries provide enough blood ow to prevent necrosis and improve function.
Conclusion
Local application of brin sealant with deferoxamine around the excised artery signi cantly accelerated capillarization and angiogenesis in a rabbit model of hind limb ischemia.
We have shown that a brin sealant administered locally may serve as an effective depot for slow delivery of deferoxamine that accelerates angiogenesis. Shireman et al 3 6 recently showed that brin sealant also serves as a depot for the slow release of VEGF and heparin.
Use of brin sealant and deferoxamine to stimulate vessel formation have potential for treating critical limb ischemia and other conditions that require enhancing angiogenesis.
